Navigation Links
IVI announces the prequalification of innovative cholera vaccine by the World Health Organization
Date:11/11/2011

3 million cases requiring treatment and about 94,000 deaths are due to cholera in endemic countries. The large outbreak that erupted in Haiti in October 2010 demonstrates that the incidence and severity of the disease can shift dramatically over a short period of time. The Haitian health ministry reported that this outbreak had caused 194,095 cumulative cases and 3,819 deaths by January 16, 2011.

Also, West and Central Africa have recently been besieged by a major outbreak across the region. According to UNICEF, 85,000 cholera cases and 2,466 deaths have been reported this year so far, potentially making it one of the worst outbreaks in the region's history. Deploying Shanchol, in conjunction with other preventive interventions and treatment, could play a key role in saving lives both in countries where the disease is endemic and in settings of natural disasters or humanitarian crises.

"In light of the devastating cholera outbreaks in Haiti, Pakistan, Nepal and in several countries of Africa, there is a clear need for a solution to halt the countless deaths and suffering," said Dr. Loucq. "A vaccine like Shanchol should positively impact public health efforts to control cholera in these countries. Now that Shanchol is WHO prequalified, IVI is looking forward to working with governments and other organizations to introduce this vaccine and to make it widely available for use around the world."

"This demonstrates the power of vaccines to prevent epidemic diseases in people at risk," said Dr. Regina Rabinovich, Director of Infectious Diseases at the Bill & Melinda Gates Foundation. "We must continue to work together to ensure that everyone has access to affordable vaccines, no matter where they live."


'/>"/>
Contact: Tae Kyung Byun
tkbyun@ivi.int
82-119-773-6071
International Vaccine Institute
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. AMRI announces collaboration agreement with Lilly for in-sourced chemistry services
2. University of Michigan announces Eric J. Topol Professorship in Cardiovascular Medicine
3. Peter Thiel announces Breakout Labs to energize innovation
4. ESC announces review of Atrial Fibrillation Guidelines
5. The Waxman Foundation announces $25,000 grant in B-cell lymphoma research
6. INFORMS journal announces special issue on using logistics, analytics in humanitarian relief
7. ASTRO announces 2011 Fellows class
8. The New York Stem Cell Foundation announces new initiative for Parkinsons disease
9. AFAR announces the 2011 Hartford Scholars in Geriatric Medicine
10. AGA announces prestigious recognition award recipients
11. Sanofi Pasteur announces FDA approval of menactra meningococcal conjugate vaccine indication for infants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... Decene is an alkene with the formula ... atoms with one double bond. 1-Decene enters all ... be used as a co-monomer in certain copolymers ... oxo alcohols, synthetic lubricants, synthetic fatty acids, and ... 10% customization on this report. , http://www.micromarketmonitor.com/contact/2523613387-request_for_customization.html ...
(Date:7/30/2014)... 2014 The Europe Phytochemicals & plant ... plant extracts market in Europe with analysis and forecast ... Europe is estimated to grow from around 710.18$ million ... CAGR of 8.4%, for the given period. , Browse ... extracts market report, to get an idea of the ...
(Date:7/30/2014)... diagnosed with depression as preschoolers are likely to suffer ... research shows. , Depressed preschoolers were 2.5 times more ... middle school than kids who were not depressed at ... School of Medicine in St. Louis. , Their study ... American Journal of Psychiatry . , "It,s the same ...
(Date:7/30/2014)... Bringing Disney Excellence to Central Iowa ... the Central Iowa Chapter of the Association for Talent ... renowned professional development course, “Disney’s Approach to Business Excellence,” ... world class workshop will inspire area professionals from businesses ... and satisfy customers. , “Disney 'magic' as I call ...
(Date:7/30/2014)... organs for transplants sounds like something out of a ... day make actual kidneys, livers, hearts and other organs ... journal Langmuir , scientists are reporting new understanding ... a step closer to realizing their goal of making ... and colleagues note that this idea of producing tissues ...
Breaking Medicine News(10 mins):Health News:Europe 1-decene Market is Expected to Reach 251.7 thousand MT in 2018 - New Report by MicroMarket Monitor 2Health News:Europe 1-decene Market is Expected to Reach 251.7 thousand MT in 2018 - New Report by MicroMarket Monitor 3Health News:Europe 1-decene Market is Expected to Reach 251.7 thousand MT in 2018 - New Report by MicroMarket Monitor 4Health News:Europe Phytochemicals & Plant Extracts (Nutraceuticals) Market is Expected to Reach $1,150.64 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Phytochemicals & Plant Extracts (Nutraceuticals) Market is Expected to Reach $1,150.64 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Phytochemicals & Plant Extracts (Nutraceuticals) Market is Expected to Reach $1,150.64 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Europe Phytochemicals & Plant Extracts (Nutraceuticals) Market is Expected to Reach $1,150.64 Million in 2018 - New Report by MicroMarket Monitor 5Health News:Many depressed preschoolers still suffer in later school years 2Health News:Many depressed preschoolers still suffer in later school years 3Health News:Central Iowa Chapter of ATD Hosts Exclusive Disney Institute for Central Iowa Businesses 2Health News:Central Iowa Chapter of ATD Hosts Exclusive Disney Institute for Central Iowa Businesses 3
... study finds , THURSDAY, Dec. 6 (HealthDay News) -- ... she receives surgery after a breast cancer diagnosis, U.S. ... Medical Institutions in Baltimore also found that a lengthy ... , Factors such as socioeconomic status and the cumulative ...
... 6 SGX Pharmaceuticals, Inc.,(Nasdaq: SGXP ) announced today ... treatment of chronic myelogenous leukemia,(CML) at the upcoming American Society ... held December 8th - 11th, 2007 in,Atlanta, Georgia., , ... listed below:, Date: ...
... 6 Arete Therapeutics Inc., a,privately-held biopharmaceutical company ... cardiovascular, inflammatory and,metabolic diseases, today announced the appointment ... "We are very pleased to welcome Don ... operational insights will be of great benefit to ...
... New Product Name Also Unveiled in Ongoing ... Dec. 6 Favrille, Inc. (Nasdaq:,FVRL), a ... treatment of cancer, announced that new data,including ... 2 clinical,trial of Specifid(TM) (formerly FavId(R)), will ...
... US Oncology, the nation,s leading,oncology services company, today ... president and chief operating officer. The appointment,becomes effective ... operating experience, combined with his work in,large diversified ... Bruce Broussard, president of US Oncology.,"His proven success ...
... Wagoner on new data showing first increase in U.S.,teen ... that the,dramatic decrease in teen pregnancy rates in the ... a screeching halt. This unwelcome,development should not come as ... success over the last decade -- the decline in ...
Cached Medicine News:Health News:Black Women Wait Longer for Breast Cancer Surgery 2Health News:SGX Pharmaceuticals BCR-ABL Program to be Presented at the American Society of Hematology 49th Annual Meeting and Exposition 2Health News:SGX Pharmaceuticals BCR-ABL Program to be Presented at the American Society of Hematology 49th Annual Meeting and Exposition 3Health News:SGX Pharmaceuticals BCR-ABL Program to be Presented at the American Society of Hematology 49th Annual Meeting and Exposition 4Health News:Arete Therapeutics Appoints Donald Santel to Board of Directors 2Health News:Favrille to Report New Data on FavId (Now Specifid) at American Society of Hematology Annual Meeting 2Health News:Favrille to Report New Data on FavId (Now Specifid) at American Society of Hematology Annual Meeting 3Health News:Favrille to Report New Data on FavId (Now Specifid) at American Society of Hematology Annual Meeting 4Health News:Favrille to Report New Data on FavId (Now Specifid) at American Society of Hematology Annual Meeting 5Health News:US Oncology Appoints Glen Laschober EVP & Chief Operating Officer 2
(Date:7/30/2014)... and NEW YORK , July 30, ... developer of new products for oncology supportive care, announced ... , has been featured in an article on OncLive.com ... in Head and Neck Cancers."  Dr. Steve Sonis ... on the growing demand seen in the oncology community ...
(Date:7/30/2014)... 2014 /PRNewswire-iReach/ -- This is a professional and ... sodium (CAS 9041-08-1) & calcium (CAS 37270-89-6) industry. ... Heparin sodium (CAS 9041-08-1) & calcium (CAS 37270-89-6) ... report then explores global and China,s top manufacturers ... 37270-89-6) listing their product specification, capacity, production value, ...
(Date:7/30/2014)... , July 30, 2014   Medical Equipment ... have been awarded a Department of Defense (US Army) ... to supply a mobile MRI diagnostic machine and technical ... Business (WOSB) through the Small Business Administration (SBA), Medical ... the field with the latest medical diagnostic equipment. The ...
Breaking Medicine Technology:Access Pharmaceuticals Featured On OncLive.com 2Access Pharmaceuticals Featured On OncLive.com 3Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 2Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 3Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 4Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 5Medical Equipment Solutions Corp. Awarded $2 Million contract To Service DoD 2
... a leading provider of next generation sequencing assays ... brand name immunoSEQ, announced today it has changed ... (Logo:  http://photos.prnewswire.com/prnh/20120103/SF28632LOGO ) ... the company,s original immune profiling business as well ...
... Inc., a privately-held, commercial-stage, healthcare company focused on the ... nervous system disorders, announced today that Holger Kunze has ... and as a member of the company,s Board of ... appointed as a member of Accera,s BoD. ...
Cached Medicine Technology:Adaptive TCR Changes Name to Adaptive Biotechnologies 2Adaptive TCR Changes Name to Adaptive Biotechnologies 3Accera, Inc. Elects Industry Veteran Holger Kunze as CEO and as a Member of the Company's Board of Directors 2Accera, Inc. Elects Industry Veteran Holger Kunze as CEO and as a Member of the Company's Board of Directors 3
... Amvex offers a complete line of ... and CO 2 . They are ... calibrations to best suit your application. ... specific to the gas in use, ...
... a complete line of flowmeters, available ... 2 . They are all available ... best suit your application. With color ... the gas in use, the Amvex ...
... of flowmeters, available in oxygen, air, heliox and CO ... of calibrations to best suit your application. With color ... use, the Amvex Flowmeter is a user friendly device., ... For Power Take-Off add PT to the end of ...
... complete line of flowmeters, available in oxygen, air, heliox ... a variety of calibrations to best suit your application. ... gas in use, the Amvex Flowmeter is a user ... with I. For Power Take-Off add PT to the ...
Medicine Products: